[1] 郑方圆,王雪梅,王新利.重组人生长激素治疗对特发性矮小儿童的糖脂代谢及甲状腺功能的影响[J].中国当代儿科杂志,2014,16(12):1236-1240. [2] 李正秋,刘康香,马步军,等.重组人生长激素治疗青春期前特发性矮小症60例疗效分析[J].医学临床研究,2012,29(3): 431-433. [3] Hoffman AR, Kuntze I E, Baptists J, et al.Growth hormone (GH) replacement therapy in adult-onset GH deficiency: Effects on body composition in men and women in a double-blind, randomize, placebo-contolled trial[J]. J Clin Endocrinology Metab, 2004, 89(5): 2048-2056. [4] 曾燕,胡红.重组人生长激素治疗在改善生长激素缺乏症患儿发育及代谢指标方面短期疗效及安全性评价[J].南京医科大学学报,2015,35(7):1031-1033. [5] 梁雁,罗小平.高度重视重组人生长激素在儿科临床的规范化应用及安全性监测[J].中华儿科杂志,2013,51(6):401-405. [6] Trepp R, Fliick M, Stetter C, et al.Effect of GH on human skeletal muscle lipid metabolism in GH deficiency[J]. Am J Physiol Endocrinol Metab, 2008, 294(6): 1127-1134. [7] Lans R, Paoli M,Carrillo E, et al.Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency: relation to postprondial dyslipidemia[J]. J Pediatr, 2004, 145(5): 657-661. [8] 梁晓红. 重组人生长激素治疗3类青春期前矮小患儿的疗效分析[J].中国妇幼健康研究,2015,26(2):258-261. [9] Kim DS, Itoh E, Iida K, et al.Growth hormone increases mRNA levels of PPARdelata and Foxol in skeletal of growth hormone deficient lit/lit mice[J]. Endocr J, 2009, 56(1): 141-147. [10] 傅春江,何作云,王旭开,等. 重组生长激素对兔冠状动脉粥样硬化的影响[J]. 重庆医学,2008, 37(6):572-573. [11] 刘莉,刘亚莉,马爽,等.瘦素对体外培养大鼠脂肪细胞ACC、AMPK表达影响[J]. 中国公共卫生,2010,26(9):1166-1167. |